MXPA02011053A - Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos. - Google Patents

Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.

Info

Publication number
MXPA02011053A
MXPA02011053A MXPA02011053A MXPA02011053A MXPA02011053A MX PA02011053 A MXPA02011053 A MX PA02011053A MX PA02011053 A MXPA02011053 A MX PA02011053A MX PA02011053 A MXPA02011053 A MX PA02011053A MX PA02011053 A MXPA02011053 A MX PA02011053A
Authority
MX
Mexico
Prior art keywords
compounds
derivatives
amino carboxy
novel spiro
carboxy compounds
Prior art date
Application number
MXPA02011053A
Other languages
English (en)
Inventor
Kenneth Curry
Original Assignee
Kenneth Curry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth Curry filed Critical Kenneth Curry
Publication of MXPA02011053A publication Critical patent/MXPA02011053A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invencion se refiere a novedosos compuestos aminocarboxi de espiro[2,4] heptano y derivados de los mismos terapeuticamente activos; tambien se provee un metodo para preparar compuestos de Formula (I) (ver formula) y composiciones farmaceuticas que comprenden los compuestos; los novedosos compuestos actuan como moduladores de receptores de glutamato metabotropico y, como tales, son utiles para tratar enfermedades del sistema nervioso central relacionadas con el sistema receptor de glutamato metabotropico.
MXPA02011053A 2000-05-11 2001-05-11 Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos. MXPA02011053A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2308536 2000-05-11
PCT/CA2001/000650 WO2001085669A1 (en) 2000-05-11 2001-05-11 Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof

Publications (1)

Publication Number Publication Date
MXPA02011053A true MXPA02011053A (es) 2004-08-19

Family

ID=4166157

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011053A MXPA02011053A (es) 2000-05-11 2001-05-11 Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.

Country Status (8)

Country Link
US (1) US20040077599A1 (es)
EP (1) EP1280760B1 (es)
AT (1) ATE265419T1 (es)
AU (1) AU2001256039A1 (es)
DE (1) DE60103050T2 (es)
MX (1) MXPA02011053A (es)
NZ (1) NZ522674A (es)
WO (1) WO2001085669A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042408A2 (en) 2000-11-27 2002-05-30 The Procter & Gamble Company Detergent products, methods and manufacture
NZ533699A (en) * 2001-12-27 2006-05-26 Taisho Pharmaceutical Co Ltd 6-fluorobicyclo[3.1.0]hexane derivatives
US20040077616A1 (en) * 2002-10-22 2004-04-22 Bennani Youssef L. Spirocyclopropyl amides and acids and their therapeutic applications
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
MY152078A (en) 2007-09-14 2014-08-15 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
AU2008297877C1 (en) 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
CA2704436C (en) 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
JP5656848B2 (ja) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体
RU2512283C2 (ru) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EA020671B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
PT2430022E (pt) 2009-05-12 2013-12-26 Janssen Pharmaceuticals Inc Derivados de 1,2,3-triazolo[4,3-a]piridina e a sua utilização para o tratamento ou prevenção de doenças neurológicas e psiquiátricas
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130084A1 (de) * 1971-06-18 1973-01-04 Gruenenthal Chemie 1,1-bis-(carbamoyl-oxymethyl)cyclopropanderivate und verfahren zu deren herstellung
US5500420A (en) * 1993-12-20 1996-03-19 Cornell Research Foundation, Inc. Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia

Also Published As

Publication number Publication date
DE60103050T2 (de) 2005-01-20
NZ522674A (en) 2004-10-29
US20040077599A1 (en) 2004-04-22
DE60103050D1 (de) 2004-06-03
EP1280760B1 (en) 2004-04-28
WO2001085669A1 (en) 2001-11-15
ATE265419T1 (de) 2004-05-15
EP1280760A1 (en) 2003-02-05
AU2001256039A1 (en) 2001-11-20

Similar Documents

Publication Publication Date Title
MXPA02011053A (es) Compuestos novedosos de carboxi amino espiro (2,4)heptano y derivados de los mismos.
MXPA02001340A (es) Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos.
HU9602522D0 (en) Heterocyclic compounds, their preparation and use
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA02010405A (es) Derivados de aminocarboxialquilo novedosos de acido barbiturico.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
SE9503924D0 (sv) Novel opioid peptides
MX9805289A (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen una afinidad por los receptores de la bradicinina.
WO2002060392A3 (en) Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
AU6999796A (en) Heterocyclic compounds as bradykinin antagonists
BR9910130A (pt) Derivados de cubana como antagonistas de receptor de glutamato metabotrópico e processo para a sua preparação
HU907025D0 (en) Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance
MXPA02000242A (es) Analogos de 2-aminoindano.
GB9515411D0 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
WO2001002340A3 (en) Novel aminoindanes
GEP19991869B (en) Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists
NO20000655D0 (no) 8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorer
AU6851396A (en) Novel fused isoquinolines as dopamine receptor ligands
UA74421C2 (uk) Похідні індолону, які є антагоністами gal3 рецептора для лікування депресії і/або тривоги та композиції, придатні для такого лікування
AU5398300A (en) Excitatory amino acid receptor modulators
AU2287197A (en) Heterocyclic compounds and their preparation and use
MX9603343A (es) Antagonistas del receptor endotelial, procedimiento para preparar dichos compuestos y preparaciones farmaceuticas que los contienen.
WO2004024709A3 (en) Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors
DE69824410D1 (en) Antithrombosemittel

Legal Events

Date Code Title Description
FA Abandonment or withdrawal